About MTS Medication Technologies
MTS Medication Technologies is a company based in St. Petersburg (United States) founded in 1984 was acquired by Omnicell in May 2012. MTS Medication Technologies has raised $13 million across 1 funding round from investors including Omnicell, Bank of America and Berwind. MTS Medication Technologies operates in a competitive market with competitors including Parata Systems, NewIcon, Rowa, Med Management and Centred Solutions, among others.
- Headquarter St. Petersburg, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Mts Medication Technologies, Inc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of MTS Medication Technologies
MTS Medication Technologies has successfully raised a total of $13M through 1 strategic funding round. The most recent funding activity was a Series B round of $13 million completed in June 2004. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in MTS Medication Technologies
MTS Medication Technologies has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include Omnicell, Bank of America and Berwind.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Berwind is operated as a family-owned investment management company.
|
Locked | Locked | Locked | |
|
Excellere Partners is engaged in private equity investments.
|
Locked | Locked | Locked | |
|
Commercial banking and asset management services are offered worldwide.
|
Locked | Locked | Locked |
Investor details for MTS Medication Technologies
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by MTS Medication Technologies
Investment portfolio details for MTS Medication Technologies
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - MTS Medication Technologies
Detailed financials for MTS Medication Technologies
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Mts Medication Technologies Comparisons
Peer comparison for MTS Medication Technologies
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of MTS Medication Technologies
MTS Medication Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Parata Systems, NewIcon, Rowa, Med Management and Centred Solutions, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Automated pharmacy dispensing and adherence packaging solutions are provided.
|
|
| Locked | Locked | Locked |
Pharmacy automation storage solutions are provided for hospitals and pharmacies.
|
|
| Locked | Locked | Locked |
Automated pharmacy dispensing robots are developed for efficient medicine handling.
|
|
| Locked | Locked | Locked |
Online platform for compliance aid and pharmacy automation
|
|
| Locked | Locked | Locked |
Offers software and technology for automated pharmacy dispensing workflows globally.
|
Detailed competitors of MTS Medication Technologies
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Mts Medication Technologies
Complete news archive for MTS Medication Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about MTS Medication Technologies
MTS Medication Technologies was founded in 1984 and raised its 1st funding round 20 years after it was founded.
MTS Medication Technologies is headquartered in St. Petersburg, United States. It is registered at St. Petersburg, Florida, United States.
MTS Medication Technologies is a funded company, having raised a total of $13M across 1 funding round to date.
MTS Medication Technologies (acquired by Omnicell) has developed medication adherence packaging systems. The system enables the pharmacies to manage medication dispensing and administration. The company has developed automated packaging machinery and consumables.
MTS Medication Technologies's top competitors include Parata Systems, Synergy Medical and NewIcon.
MTS Medication Technologies has 4 investors. Key investors include Omnicell, Bank of America, Berwind, and Excellere Partners.